Pharmaceutical Information |
Drug Name |
Rimexolone |
Drug ID |
BADD_D01946 |
Description |
Rimexolone is a 1% eye drop solution is a glucocorticoid steroid. It is used to treat inflammation in the eye. It is marketed as Vexol. |
Indications and Usage |
For the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uveitis. |
Marketing Status |
Discontinued |
ATC Code |
H02AB12; S01BA13 |
DrugBank ID |
DB00896
|
KEGG ID |
D05729
|
MeSH ID |
C013769
|
PubChem ID |
5311412
|
TTD Drug ID |
D0D2TN
|
NDC Product Code |
60870-0423 |
Synonyms |
rimexolone | 11 beta-hydroxy-16 alpha,17 alpha,21-trimethylpregna-1,4-diene-3,20-dione | Rimexel | Vexol | Org 6216 | Org-6216 |
|
Chemical Information |
Molecular Formula |
C24H34O3 |
CAS Registry Number |
49697-38-3 |
SMILES |
CCC(=O)C1(C(CC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C)C |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|